These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 96741)

  • 1. Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood.
    Trompeter RS; Thomson PD; Barratt TM; Soothill JF
    Arch Dis Child; 1978 May; 53(5):430-2. PubMed ID: 96741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.
    Buckell NA; Gould SR; Day DW; Lennard-Jones JE; Edwards AM
    Gut; 1978 Dec; 19(12):1140-3. PubMed ID: 105970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
    BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Counahan R; Ogg CS; Soothill JF
    Arch Dis Child; 1977 Jun; 52(6):462-3. PubMed ID: 879831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic nephrotic syndrome. Effect of oral cromoglycate].
    Laurent J; André C; Rostocker G; Lagrue G
    Presse Med; 1990 May; 19(20):950-2. PubMed ID: 2141132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disodium cromoglycate in the treatment of allergic conditions of the nose].
    Balle VH; Illum P; Meistrup-Larsen U; Olesen KF
    Ugeskr Laeger; 1979 Jul; 141(28):1906-8. PubMed ID: 112749
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid-responsive and nephrotic syndrome and allergy: clinical studies.
    Meadow SR; Sarsfield JK
    Arch Dis Child; 1981 Jul; 56(7):509-16. PubMed ID: 6791592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
    Yoshikawa N; Ito H; Takekoshi Y; Honda M; Awazu M; Iijima K; Nakamura H; Seino Y; Takeda N; Hattori S; Matsuda I
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of bronchial asthma in childhood using disodium cromoglycate].
    Schmidt E; Pfingsten S
    Z Allgemeinmed; 1973 May; 49(14):686-90. PubMed ID: 4201929
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind crossover trial of disodium cromoglycate in asthmatic patients living under environmental control.
    Toshner D; Frank M
    Isr J Med Sci; 1974 May; 10(5):509-14. PubMed ID: 4212884
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.
    Whorwell PJ; Whorwell GM; Bamforth J; Colin Jones D; Down P; Edwards A; Gent AE; Golding P; Gough KR; Hellier MD; Isaacson P; Loehry CA; Milton-Thompson GJ; Smith CL; Waldram RP; Wright R
    Postgrad Med J; 1981 Jul; 57(669):436-8. PubMed ID: 6118859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.
    Mani V; Lloyd G; Green FH; Fox H; Turnberg LA
    Lancet; 1976 Feb; 1(7957):439-41. PubMed ID: 55715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind controlled trial of disodium cromoglycate in seasonal allergic rhinitis.
    Anderson WV; Marshall NE; Clark MC
    Practitioner; 1972 May; 208(247):676-9. PubMed ID: 4627165
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of disodium cromoglycate in the treatment of Crohn's disease.
    Williams SE; Grundman MJ; Baker RD; Turnberg LA
    Digestion; 1980; 20(6):395-8. PubMed ID: 6773843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disodium cromoglycate in vernal catarrh.
    Bansal Sl; Dhir SP; Jain IS
    Indian J Ophthalmol; 1981 Jan; 28(4):179-81. PubMed ID: 6793510
    [No Abstract]   [Full Text] [Related]  

  • 18. [The first experience of using membranotropic agents in the treatment of the nephrotic syndrome].
    Ignatova MS; Moskaleva ES; Kopyleva SD; Katysheva OV
    Ter Arkh; 1991; 63(6):122-5. PubMed ID: 1948728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disodium cromoglycate in the treatment of chronic proctitis.
    Heatley RV; Calcraft BJ; Rhodes J; Owen E; Evans BK; Whitehead RH
    Acta Allergol; 1977; Suppl 13():87-94. PubMed ID: 415502
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of disodium cromoglycate in vernal conjunctivitis.
    Vajpayee R; Kumar S; Sharma M
    Indian J Ophthalmol; 1985; 33(3):151-3. PubMed ID: 3939423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.